USFDA7 Nov 2025, 07:11 pm
Jeevan Scientific Technology Ltd Completes US FDA Remote Interactive Evaluation (RIE) Successfully
AI Summary
Jeevan Scientific Technology Ltd (BSE Scrip Code: 538837) has successfully completed a Remote Interactive Evaluation (RIE) conducted by the United States Food and Drug Administration (US FDA) for its Clinical Pharmacology facility. The evaluation took place from 17th October, 2025 to 6th November, 2025, focusing on reviewing BA/BE studies and operations, systems, and procedures. The RIE was completed without any critical observations, indicating a successful evaluation.
Key Highlights
- Jeevan Scientific Technology Ltd successfully completes US FDA's Remote Interactive Evaluation (RIE)
- RIE conducted for the Clinical Pharmacology facility from 17th October to 6th November, 2025
- US FDA's RIE focused on reviewing BA/BE studies and operations, systems, and procedures
- No critical observations were made during the RIE
- Evaluation indicates successful compliance with US FDA regulations for the facility